In practice, the emotional journey is often the same: urgency is followed by confusion, then a quiet fear that appearance-based metrics have misled them
The mechanism of action involves binding to both GIP and GLP-1 receptors, which are naturally occurring hormones released from the gut in response to food intake
Several factors explain why Lilly has become the biggest winner : Record GLP-1 Sales: Mounjaro and ZepBound Source EvaluatePharma Lillys GLP-1 portfolio is led by Mounjaro (tirzepatide) and ZepBound (tirzepatide) , both based on the dual GLP-1/GIP agonist tirzepatide but marketed separately for diabetes and obesity
Common formulations include 10mg, 12mg, 15mg, or 20mg per vial
Reduces Appetite & Cravings: Crucially, it acts directly on the brain's appetite centers, leading to a significant reduction in hunger and food cravings
Quality verification becomes important regardless of source